Penobscot Investment Management Company Inc. Sells 5,455 Shares of Agilent Technologies, Inc. $A

Penobscot Investment Management Company Inc. cut its position in Agilent Technologies, Inc. (NYSE:A) by 47.9% during the 1st quarter, HoldingsChannel reports. The firm owned 5,935 shares of the medical research company’s stock after selling 5,455 shares during the quarter. Penobscot Investment Management Company Inc.’s holdings in Agilent Technologies were worth $676,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC lifted its holdings in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after acquiring an additional 270 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after acquiring an additional 769 shares in the last quarter. Geneos Wealth Management Inc. raised its position in shares of Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after purchasing an additional 212 shares during the period. Acadian Asset Management LLC raised its position in shares of Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after purchasing an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Agilent Technologies during the second quarter worth about $273,000.

Agilent Technologies Stock Down 1.8%

NYSE:A opened at $128.77 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The company has a market cap of $36.37 billion, a PE ratio of 25.86, a PEG ratio of 2.33 and a beta of 1.25. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.27. The stock has a 50-day simple moving average of $124.91 and a 200 day simple moving average of $125.73.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on A shares. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Robert W. Baird lifted their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Sanford C. Bernstein assumed coverage on shares of Agilent Technologies in a report on Friday, June 26th. They issued an “outperform” rating and a $155.00 price target for the company. Finally, Barclays increased their price objective on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $160.88.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.